Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Clinical Trial ID NCT00805233

PubWeight™ 3.34‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00805233

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunology of age-related macular degeneration. Nat Rev Immunol 2013 2.14
2 The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) 2010 1.29
Next 100